Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Muir

Showing results (401-410 of 494) with videos related to

Pageof 50
Sort By:
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Gastroenterology|August 1, 2017
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver ForumYuval A Patel, Joanne C Imperial, Andrew J Muir, et al.
Pharmacogenetics and Genomics|September 25, 2013
Predictors of consent to pharmacogenomics testing in the IDEAL studyAlison B Jazwinski, Paul J Clark, Alexander J Thompson, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotypeAlexander J Thompson, Andrew J Muir, Mark S Sulkowski, et al.
Human Molecular Genetics|May 18, 2000
Disruption of two novel genes by a translocation co-segregating with schizophreniaJ K Millar, J C Wilson-Annan, S Anderson, et al.
Hepatology Communications|July 5, 2024
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitisDouglas Thorburn, Diana J Leeming, William T Barchuk, et al.
Molecular Genetics and Metabolism Reports|November 25, 2021
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type IIIGhada Hijazi, Anna Paschall, Sarah P Young, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 24, 2007
A genome-wide linkage study in families with major depression and co-morbid unexplained swellingCarl A Anderson, Alan Maclean, Matthew G Dunnigan, et al.
Psychiatric Genetics|August 30, 2001
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorderR S Devon, S Anderson, P W Teague, et al.
Pageof 50

Showing results (401-410 of 494) with videos related to

Sort By:
Pageof 50
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Gastroenterology|August 1, 2017
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver ForumYuval A Patel, Joanne C Imperial, Andrew J Muir, et al.
Pharmacogenetics and Genomics|September 25, 2013
Predictors of consent to pharmacogenomics testing in the IDEAL studyAlison B Jazwinski, Paul J Clark, Alexander J Thompson, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Hepatology (Baltimore, Md.)|October 5, 2010
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotypeAlexander J Thompson, Andrew J Muir, Mark S Sulkowski, et al.
Human Molecular Genetics|May 18, 2000
Disruption of two novel genes by a translocation co-segregating with schizophreniaJ K Millar, J C Wilson-Annan, S Anderson, et al.
Hepatology Communications|July 5, 2024
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitisDouglas Thorburn, Diana J Leeming, William T Barchuk, et al.
Molecular Genetics and Metabolism Reports|November 25, 2021
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type IIIGhada Hijazi, Anna Paschall, Sarah P Young, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 24, 2007
A genome-wide linkage study in families with major depression and co-morbid unexplained swellingCarl A Anderson, Alan Maclean, Matthew G Dunnigan, et al.
Psychiatric Genetics|August 30, 2001
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorderR S Devon, S Anderson, P W Teague, et al.
Pageof 50